Mesenchymal stem cell-conditioned medium accelerates type 2 diabetic wound healing by targeting TNF and chemokine signaling

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis reveals ACM improves angiogenesis and reduces inflammatory mediators in T2D, suggesting potential for enhanced healing.

ACM significantly accelerates wound healing in T2D rats, enhancing closure and reducing inflammation.
In vitro, ACM boosts HUVEC proliferation and angiogenesis, upregulating key growth factors like EGF and VEGF.
Transcriptome analysis exhibits downregulation of TNF and chemokine pathways, crucial for inflammation control.
ACM may serve as a novel cell-free therapy option for managing impaired wound healing in diabetes.

Huang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Observational analysis reveals ACM improves angiogenesis and reduces inflammatory mediators in T2D, suggesting potential for enhanced healing.